Tuvalu vs United Arab Emirates: The number of people with susceptibility test result for rifampicin
Tuvalu
19
in 2021
United Arab Emirates
23
in 2021
Tuvalu rank
133rd
United Arab Emirates rank
131st
The number of people with susceptibility test result for rifampicin over time
- Tuvalu
- United Arab Emirates
How they compare
United Arab Emirates currently reports 23 against 19 in Tuvalu, a difference of 4.
That makes United Arab Emirates's figure about 1.2 times Tuvalu's.
Across all 5 years both countries report, United Arab Emirates has been ahead every year.
Tuvalu ranks 133rd and United Arab Emirates ranks 131st of 155 countries.
United Arab Emirates has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Tuvalu | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 14 | 32 | 18 | United Arab Emirates |
| 2020s | 17 | 26 | 9 | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Tuvalu or United Arab Emirates?
- United Arab Emirates, at 23 against 19 in Tuvalu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Tuvalu and United Arab Emirates?
- 4, with United Arab Emirates ahead.
- How many years of comparable data are there for Tuvalu and United Arab Emirates?
- 5 years are reported by both, from 2017 to 2021.
- How do Tuvalu and United Arab Emirates rank globally for the number of people with susceptibility test result for rifampicin?
- Tuvalu ranks 133rd and United Arab Emirates ranks 131st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.